open access

Vol 69, Supp. III (2011)
Review articles
Published online: 2011-11-24
Submitted: 2012-12-28
Get Citation

Derivatives of 1,4-dihydropyridines as “priviledged structures” and their pharmacological potential

Michał Żorniak, Katarzyna Mitręga, Tadeusz F. Krzemiński

open access

Vol 69, Supp. III (2011)
Review articles
Published online: 2011-11-24
Submitted: 2012-12-28

Abstract

Derivatives of 1,4-dihydropyridine belong to group of calcium channel blockers and remain large group of antihypertensive agents. Particular chemical structure and presence of highly reactive binding groups make 1,4-dihydropyridines “privileged structures”, which can be modified and change their pharmacological effects. This fact applies to new derivatives as well as metabolites of those drugs. Particularly interesting are outcomes of experiments with metabolites of furnidypine, which tend to cause different pharmacological effect, as well as have different profile of adverse effects from mother drug. Our paper concerns with potential new possibilities of using derivatives of 1,4-dihydropyridines, as well as their metabolites, as agents of more “optimised” effect.
Kardiol Pol 2011; 69, supl. III: 100–103

Abstract

Derivatives of 1,4-dihydropyridine belong to group of calcium channel blockers and remain large group of antihypertensive agents. Particular chemical structure and presence of highly reactive binding groups make 1,4-dihydropyridines “privileged structures”, which can be modified and change their pharmacological effects. This fact applies to new derivatives as well as metabolites of those drugs. Particularly interesting are outcomes of experiments with metabolites of furnidypine, which tend to cause different pharmacological effect, as well as have different profile of adverse effects from mother drug. Our paper concerns with potential new possibilities of using derivatives of 1,4-dihydropyridines, as well as their metabolites, as agents of more “optimised” effect.
Kardiol Pol 2011; 69, supl. III: 100–103
Get Citation

Keywords

1; 4-dihydropyridines; experimental cardiology; “privileged structures”

About this article
Title

Derivatives of 1,4-dihydropyridines as “priviledged structures” and their pharmacological potential

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 69, Supp. III (2011)

Pages

100-103

Published online

2011-11-24

Keywords

1
4-dihydropyridines
experimental cardiology
“privileged structures”

Authors

Michał Żorniak
Katarzyna Mitręga
Tadeusz F. Krzemiński

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl